Lv4
770 积分 2023-03-21 加入
Harnessing CD8 T cell responses using PD-1–IL-2 combination therapy
24天前
已完结
Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm andimmune-mediated control of epithelial cancers
3个月前
已完结
Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
3个月前
已完结
FcαRI (CD89) as a Novel Trigger Molecule for Bispecific Antibody Therapy
3个月前
已完结
Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm andimmune-mediated control of epithelial cancers
4个月前
已完结
A novel bispecific antibody as an immunotherapeutic agent in hepatocellular carcinoma
4个月前
已完结
Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers
4个月前
已完结
A tumor-specific pro-IL-12 activates preexisting cytotoxic Tcells to control established tumors
5个月前
已完结
ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies
7个月前
已完结
皖公网安备34019202002308
